Abstract Details

Title Sleep Quality, Duration, Insomnia Symptoms, and Risk for Sleep Disordered Breathing in Parkinson's Disease

Topic Movement Disorders

Presentation(s) P06 - (-)

Poster/Presentation
Number 092

Objective

Background BACKGROUND: Sleep quality impacts physical health, emotional well-being, and quality of life. Sleep disordered breathing (SDB) has been associated with impaired cognition, increased risk of stroke, hypertension, atrial fibrillation, and coronary artery disease. Sleep disturbances are common non-motor complications of PD but little is known about their impact on physical, psychological and, cognitive well-being.

Design/Methods DESIGN/METHODS: 60 PD participants with a Hoehn and Yahr stage ?3 were evaluated with the Epworth Sleepiness Score (ESS), Berlin Sleep Questionnaire (BSQ), Sleep Quality Questionnaires (PSQI and PDSS), and Insomnia Symptoms.

Results RESULTS: Mean age was 65 ± 9 years, self-reported BMI was 26 ± 4 kg/m2, 95% were white and 63% were Hispanic. Participants were well educated (84% with some college or professional degree); 27% were employed (49% retired), and 83% were married. Mean UPDRS motor score was 17 ± 7 (n=26). The mean self-reported total sleep time during weekdays was 6.7 ± 1.4 hours. During the preceding month, participants reported at least some (slight to severe) difficulty with sleep initiation (43%), sleep maintenance (69%), early morning rising (45%), and non-refreshing sleep (45%). EDS was reported by 29% of the sample, and 13% ranked their sleep quality as 'fairly bad' to 'very bad'. More than one third of the population (37%) was at high risk for SDB based on BSQ.

Conclusions CONCLUSIONS: Sleep complaints and disorders are prevalent in PD and likely play an important role in overall physical health and psychological well-being. Future studies are needed to determine the role of sleep disorders on cognitive and cardiovascular health in individuals with Parkinson's disease.

Authors/Disclosures
PRESENTER	No disclosure on file
Douglas M. Wallace, MD (Miami VA HealthCare System)	No disclosure on file
	No disclosure on file
Corneliu C. Luca, MD (University of Miami)	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
James M. Meyer, PharmD (Marathon Pharmaceuticals, LLC)	No disclosure on file
Heather Katzen, PhD	Dr. Katzen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Adult Hydrocephalus Clinical Research Network. Dr. Katzen has received publishing royalties from a publication relating to health care.
Bonnie E. Levin, PhD	No disclosure on file
Carlos Singer, MD (University of Miami)	Dr. Singer has nothing to disclose.

��ɫ��

��ɫ��